CLOPITAB 150MG TABLET contains Clopidogrel which belongs to the group of medicines called Antiplatelets. CLOPITAB 150MG TABLET is used to manage blood clots (thrombi) due to atherothrombosis which may lead to atherothrombotic events such as stroke or heart attack and atherosclerotic events (myocardial infraction) in patients with atherosclerosis. It is also used to manage in-stent restenosis in patients undergo percutaneous coronary Intervention (PCI).

Platelets are very small structures in the blood which clump together during blood clotting. By managing this clumping, antiplatelet medicinal products reduce the chances of blood clots forming (a process called thrombosis).

Atherothrombosis is an inflammatory process of the arteries that affects the coronary (heart), cerebral (brain) and peripheral circulation (blood circulation to arms, hands, legs and feet) by aberrant thickening of the blood vessel wall and reducing the blood flow to the tissue that triggers the occurrence of myocardial infarction, stroke and peripheral arterial disease.

Along with this management, your doctor may advise regular blood tests to check your blood clotting time.

Avoid taking CLOPITAB 150MG TABLET, if you are allergic to Clopidogrel or have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain, severe liver disease.

Before taking CLOPITAB 150MG TABLET, inform your doctor if you are at a risk of internal bleeding, have or ever had a clot in artery of your brain (ischemic stroke) which might have occurred within the last seven days or have heart or kidney problems.

CLOPITAB 150MG TABLET is not recommended for use in pregnant and breastfeeding women. It is not recommended for use in children and adolescents (below 18 years of age). Consult your doctor before taking CLOPITAB 150MG TABLET.

The most common side effects of taking CLOPITAB 150MG TABLET are bleeding, diarrhea, abdominal pain, indigestion and heartburn. Consult your doctor if any of these above symptoms gets worse.